Blossomhill Therapeutics, Inc. (BLSM)

26.68 +0.94 (+3.65%) USD  |  NASDAQ  |  Sep 21, 16:00
26.13 -0.55 (-2.06%) After-Hours: 20:00
More

Blossomhill Therapeutics Shareholders Equity (Quarterly) : -174.78M for June 30, 2026

Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for BLSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 -174.78M
Date Value
March 31, 2026 -152.12M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
IGC Pharma, Inc. 6.132M
Cocrystal Pharma, Inc. 1.044M
CNBX Pharmaceuticals, Inc. -2.660M
GB Sciences, Inc. --
Arvinas, Inc. 562.20M

Shareholders Equity (Quarterly) Related Metrics

Total Assets (Quarterly) 124.13M
Total Liabilities (Quarterly) 298.91M
Debt to Equity Ratio -1.603
Current Ratio 5.261